Subscribe to Newsletter
Subspecialties Glaucoma, Basic & Translational Research, Pediatric

Tackling Tiny TMs

Credit: Collage images sourced from Rawpixel.com

Accounting for eight percent of blindness among the pediatric population, childhood glaucoma (CG) remains a serious and threatening disease. Although trabeculotomy and goniotomy are effective at restoring healthy outflow, they often cause extensive structural damage to the anterior angle, risking complications, such as hyphema, cyclodialysis and hypotony.

In search of alternative treatment options for CG, researchers explored the outcomes and complications of penetrating canaloplasty in a new study published in the Journal of Glaucoma (1). Aiming to maintain the established efficacy of current goniosurgeries whilst improving their safety, the team was hopeful that penetrating canaloplasty would fit the bill.

The prospective consecutive case series study involved 32 participants suffering from CG between 2017 and 2020. Using a microcatheter to achieve a 360 º cannulation of Schlemm's canal, a tension suture was left in place and thus provided an inward distension. Postoperatively, the patients were treated with levofloxacin and dexamethasone eye drops four times daily for two weeks.

In contrast to surgeries that require the removal of a large portion of the trabecular meshwork, the small trabecular meshwork fistula used in penetrating canaloplasty allows the restoration of aqueous humor outflow whilst ensuring that the majority of the trabecular meshwork remains intact. In addition to being significantly less damaging than other angle surgeries, the study showed that results of penetrating canaloplasty are comparable to conventional trabeculotomy and current minimally invasive goniosurgeries. With complete and qualified success rates presenting in 81.1 percent of eyes and 89.2 percent of all eyes, respectively, at the 12-month follow-up, it is clear that penetrating canaloplasty offers a promising pathway for the future of CG management.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. L. Rongrong et al., “Outcomes of Penetrating Canaloplasty in Childhood Glaucoma,” J Glaucoma, 32, 34 (2023). PMID: 35980844.
About the Author
Sarah Healey

Communicating stories in a way that is accessible to all was one of the focal points of my Creative Writing degree. Although writing magical realism is a fun endeavor (and one I still dabble in), getting to the heart of human stories has always been the driving motivator behind my writing. At Texere, I am able to connect with the people behind scientific breakthroughs and share their stories in a way that is impactful and engaging.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: